Clinical Trial Update: Treatment of Corneal Neovascularization With Topical Pazopanib [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on topical pazopanib for corneal neovascularization in Phase 1/2 completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Reza Dana, MD | Conditions: Corneal Neovascularization | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-11-06